InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

12.05
Delayed Data
As of Apr 27
 -0.98 / -7.52%
Today’s Change
1.86
Today|||52-Week Range
19.68
+128.22%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 25.00. The median estimate represents a +107.47% increase from the last price of 12.05.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in InVivo Therapeutics Holdings Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$0.00
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.00%
 
 
 
 
 
 
Growthannually -215.00%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account